Mometamax 3 mg/g 15 g
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
Otic suspension for the treatment of otitis externa in dogs caused by yeast susceptible to clotrimazole (Malassezia pachydermatis) and bacteria susceptible to gentamicin (Pseudomonas spp. [including P. aeruginosa], coagulase-positive staphylococci [including S. aureus and S. intermedius], Enterococcus faecalis, Proteus mirabilis and beta-hemolytic streptococci), and for the reduction of tissue inflammation that is commonly associated with this condition.
Product Details
| DIN (Drug Identification Number) | 02344688 |
| Active Ingredients | gentamicin sulfate, equivalent to 3 mg gentamicin base; mometasone furoate monohydrate equivalent to 1 mg mometasone furoate; and 10 mg clotrimazole, in a mineral oil-based system containing a plasticized hydrocarbon gel |
| Approved For | Dog |
| Therapeutic Use | Antibiotic, Antifungal, Glucocorticoid |
| Form | Suspension |
| Route of Administration | Otic |
| Strength / Concentration | 3 mg/g mg/g |
| Pack Size | 15 g |
Safety & Storage
Storage: Ambient
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Merck |
|---|---|
| DIN | 2344688 |
| Active Ingredient | gentamicin sulfate, equivalent to 3 mg gentamicin base; mometasone furoate monohydrate equivalent to 1 mg mometasone furoate; and 10 mg clotrimazole, in a mineral oil-based system containing a plasticized hydrocarbon gel |
| Strength | 3 mg/g mg/g |
| Pack Size | 15 g |
Storage & Shipping
| Shipping Weight | 0.03 kg |
|---|---|
| Storage Conditions | Ambient |
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.
